These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6988266)

  • 21. Synthesis of two biologically active insulin analogues with modifications at the N-terminal and N- and C-terminal amino acid residues.
    Cosmatos A; Okada Y; Katsoyannis PG
    Biochemistry; 1976 Sep; 15(18):4076-82. PubMed ID: 963022
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The biological properties of insulins with tyrosine replaced by phenylalanine at positions 14 and 19 of the A chain.
    Cockram CS; Jones RH; Sönksen PH
    Diabet Med; 1985 Jul; 2(4):241-4. PubMed ID: 2951075
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biological and immunological properties of human gastrin I analogues.
    Wünsch E; Moroder L; Gillessen D; Soerensen UB; Bali JP
    Hoppe Seylers Z Physiol Chem; 1982 Jun; 363(6):665-9. PubMed ID: 7106709
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Crosslinked insulins: preparation, properties, and application.
    Brandenburg D; Gattner HG; Schermutzki W; Schüttler A; Uschkoreit J; Weimann J; Wollmer A
    Adv Exp Med Biol; 1977; 86A():261-82. PubMed ID: 335839
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Electrophoresis of ( 35 S) sulphated insulin. Immunological and biological properties of the isolated electrophoretic components.
    Thomas JH
    Horm Metab Res; 1971 May; 3(3):207-12. PubMed ID: 5123998
    [No Abstract]   [Full Text] [Related]  

  • 26. Structure and function relationships of insulin. Preparation, characterization, and biological activity of three bovine insulin derivatives selectively modified at the NH2-terminal of the B chain.
    Yeung CW; Moule ML; Yip CC
    J Biol Chem; 1979 Oct; 254(19):9453-7. PubMed ID: 489544
    [No Abstract]   [Full Text] [Related]  

  • 27. The stability of A1,B29-adipoylinsulin to chemical and enzymatic degradation.
    Robinson SM; Lübke K
    Hoppe Seylers Z Physiol Chem; 1978 Feb; 359(2):225-9. PubMed ID: 649057
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunological and biological properties of iodoinsulin labeled with one or less atoms of iodine per molecule.
    Arquilla ER; Ooms H; Mercola K
    J Clin Invest; 1968 Mar; 47(3):474-87. PubMed ID: 5637137
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Production and characterization of specific antibodies for evaluation of glycated insulin in plasma and biological tissues.
    McKillop AM; McCluskey JT; Boyd AC; Mooney MH; Flatt PR; O'Harte FP
    J Endocrinol; 2000 Oct; 167(1):153-63. PubMed ID: 11018763
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Intramolecular modification of azisobutyrylinsulin and the use of the modified hormone for the synthesis of polymeric derivatives].
    Vlasov GP; Izvarina NL; Illarionova NG
    Biokhimiia; 1981 May; 46(5):942-50. PubMed ID: 7028141
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A sensitive radioimmunoassay for human proinsulin, with sequential use of antisera to C-peptide and insulin.
    Ward WK; Paquette TL; Frank BH; Porte D
    Clin Chem; 1986 May; 32(5):728-33. PubMed ID: 3516448
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Covalent linking of photoreactive insulin to adipocytes produces a prolonged signal.
    Brandenburg D; Diaconescu C; Saunders D; Thamm P
    Nature; 1980 Aug; 286(5775):821-2. PubMed ID: 6995859
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Studies on the biological activity of degraded insulins and insulin fragments.
    Kikuchi K; Larner J; Freer RJ; Day AR; Morris H; Dell A
    J Biol Chem; 1980 Oct; 255(19):9281-8. PubMed ID: 6773963
    [No Abstract]   [Full Text] [Related]  

  • 34. [Biological and immunological activity of chemically modified insulins].
    Rager K; Kemmler W; Schauder P
    Hoppe Seylers Z Physiol Chem; 1969 Jun; 350(6):717-20. PubMed ID: 5799710
    [No Abstract]   [Full Text] [Related]  

  • 35. Structure-function studies on human growth hormone. Evidence that tertiary structure is essential for biological activity.
    Aubert ML; Bewley TA; Grumbach MM; Kaplan SL; Li CH
    Int J Pept Protein Res; 1986 Jul; 28(1):45-57. PubMed ID: 2944851
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural studies of insulin and insulin derivatives using various immunologic indicators and antibody populations.
    Arquilla ER; Dorio RJ; Brugman TM
    Diabetes; 1976 May; 25(5):397-403. PubMed ID: 57891
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sensitive RIA for the specific determination of insulin lispro.
    Bowsher RR; Lynch RA; Brown-Augsburger P; Santa PF; Legan WE; Woodworth JR; Chance RE
    Clin Chem; 1999 Jan; 45(1):104-10. PubMed ID: 9895345
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aspects of bradykinin radioimmunoassay.
    Odya CE; Goodfriend TL; Stewart JM; Peña C
    J Immunol Methods; 1978; 19(2-3):243-57. PubMed ID: 624845
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A modification of the unlabeled antibody enzyme method using heterologous antisera for the light microscopic and ultrastructural localization of insulin, glucagon and growth hormone.
    Erlandsen SL; Parsons JA; Burke JP; Redick JA; Van Orden DE; Van Orden LS
    J Histochem Cytochem; 1975 Sep; 23(9):666-77. PubMed ID: 1176760
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insulin-like activity and immunoreactive insulin content of gel-filtered protein fractions of bovine serum.
    Konijnendijk W; Bouman PR
    Diabetologia; 1970 Aug; 6(4):379-85. PubMed ID: 5452387
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.